MED MEDIFAST INC
NYSE · SEC CIK 910329 · EDGAR
- Bought, last 12 months
- $1.67M 5 purchases by 3 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 117 since 2021-07-07, latest 2026-08-28 12:47
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kiai Parsa | Dir | $1.42M | — |
| Chard Daniel R | COB, CEO, Dir | $178.7K | — |
| SCHLACKMAN SCOTT | Dir | $63.0K | — |
| Rose Jeffrey Matthew | Dir | — | — |
| Geary Elizabeth A. | Dir | — | — |
| MacKenzie Jonathan Barrett | VP, CAO, Fin | — | — |
| Thomas Andrea B | Dir | — | — |
| Maloney James P. | CFO | — | — |
Transactions 136
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-08-28 12:47 | 2026-08-26 | MED | Kiai Parsa | Dir | P - Purchase | $12.26 | +43.1K | 20.3K | New | +$529.2K |
| MI | 2026-08-26 11:47 | 2026-08-24 | MED | Kiai Parsa | Dir | P - Purchase | $12.00 | +4,329 | 19.1K | +29% | +$51.9K |
| MI | 2026-08-21 12:35 | 2026-08-19+ | MED | Kiai Parsa | Dir | P - Purchase | $11.63 | +72.5K | 19.0K | New | +$842.7K |
| M | 2026-05-28 19:34 | 2026-05-26 | MED | Rose Jeffrey Matthew | Dir | A - Grant | $0.00 | +18.4K | 18.4K | New | $0 |
| M | 2026-05-28 19:33 | 2026-05-26 | MED | Kiai Parsa | Dir | A - Grant | $0.00 | +19.3K | 19.3K | New | $0 |
| 2026-05-28 19:33 | 2026-05-26 | MED | Thomas Andrea B | Dir | A - Grant | $0.00 | +11.7K | 35.7K | +49% | $0 | |
| 2026-05-28 19:32 | 2026-05-26 | MED | SCHLACKMAN SCOTT | Dir | A - Grant | $0.00 | +11.7K | 42.2K | +38% | $0 | |
| 2026-05-28 19:31 | 2026-05-26 | MED | Geary Elizabeth A. | Dir | A - Grant | $0.00 | +11.7K | 31.2K | +60% | $0 | |
| M | 2026-05-12 19:10 | 2026-05-08+ | MED | SCHLACKMAN SCOTT | Dir | P - Purchase | $12.59 | +5,000 | 30.5K | +20% | +$63.0K |
| M | 2026-03-27 | 2026-03-13+ | MED | Maloney James P. | CFO | F - Tax | $9.64 | -4,624 | 40.9K | -10% | -$44.6K |
| M | 2026-03-27 | 2026-03-25 | MED | Maloney James P. | CFO | A - Grant | $0.00 | +35.4K | 72.0K | +96% | $0 |
| M | 2026-03-27 | 2026-03-13+ | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | F - Tax | $9.62 | -1,130 | 10.0K | -10% | -$10.9K |
| 2026-03-27 | 2026-03-25 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | A - Grant | $0.00 | +10.8K | 20.8K | +108% | $0 | |
| M | 2026-03-27 | 2026-03-25 | MED | Chard Daniel R | COB, CEO, Dir | A - Grant | $0.00 | +41.8K | 183.4K | +30% | $0 |
| M | 2026-03-27 | 2026-03-13+ | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $9.64 | -29.8K | 146.4K | -17% | -$287.3K |
| I | 2026-03-27 | 2026-03-20 | MED | Chard Daniel R | COB, CEO, Dir | P - Purchase | $10.11 | +17.7K | 17.7K | New | +$178.7K |
| 2025-06-26 | 2025-06-25 | MED | SCHLACKMAN SCOTT | Dir | A - Grant | $0.00 | +11.2K | 25.5K | +78% | $0 | |
| 2025-06-26 | 2025-06-25 | MED | Thomas Andrea B | Dir | A - Grant | $0.00 | +11.2K | 24.0K | +87% | $0 | |
| 2025-06-26 | 2025-06-25 | MED | Geary Elizabeth A. | Dir | A - Grant | $0.00 | +11.2K | 19.5K | +133% | $0 | |
| 2025-06-26 | 2025-06-25 | MED | Hoer Michael A. | Dir | A - Grant | $0.00 | +11.2K | 26.1K | +75% | $0 | |
| M | 2025-06-26 | 2025-06-25 | MED | BROWN JEFFREY J | Dir | A - Grant | $6.14 | +20.6K | 29.1K | +242% | +$126.5K |
| I | 2025-06-17 | 2025-06-13 | MED | Chard Daniel R | COB, CEO, Dir | P - Purchase | $13.13 | +381 | 149.7K | +0.3% | +$5,003 |
| 2025-03-27 | 2025-03-25 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | A - Grant | $0.00 | +7,671 | 11.1K | +221% | $0 | |
| 2025-03-27 | 2025-03-25 | MED | Chard Daniel R | COB, CEO, Dir | A - Grant | $0.00 | +125.0K | 176.2K | +244% | $0 | |
| 2025-03-27 | 2025-03-25 | MED | Maloney James P. | CFO | A - Grant | $0.00 | +24.2K | 42.3K | +133% | $0 | |
| M | 2025-03-18 | 2025-03-13+ | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $13.99 | -7,809 | 51.3K | -13% | -$109.3K |
| M | 2025-03-18 | 2025-03-13+ | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | F - Tax | $13.99 | -439 | 3,626 | -11% | -$6,141 |
| M | 2025-03-18 | 2025-03-13+ | MED | Maloney James P. | CFO | F - Tax | $14.03 | -1,396 | 18.6K | -7% | -$19.6K |
| 2024-09-17 | 2024-09-13 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | F - Tax | $18.90 | -11 | 3,906 | -0.3% | -$207.90 | |
| 2024-06-24 | 2024-06-20 | MED | Hoer Michael A. | Dir | A - Grant | $0.00 | +6,596 | 15.0K | +79% | $0 | |
| 2024-06-24 | 2024-06-20 | MED | Geary Elizabeth A. | Dir | A - Grant | $0.00 | +6,596 | 8,377 | +370% | $0 | |
| 2024-06-24 | 2024-06-20 | MED | SCHLACKMAN SCOTT | Dir | A - Grant | $0.00 | +6,596 | 14.4K | +85% | $0 | |
| M | 2024-06-24 | 2024-06-20 | MED | BROWN JEFFREY J | Dir | A - Grant | $10.39 | +12.2K | 18.0K | +211% | +$126.5K |
| 2024-06-24 | 2024-06-20 | MED | Thomas Andrea B | Dir | A - Grant | $0.00 | +6,596 | 12.8K | +105% | $0 | |
| M | 2024-03-19 | 2024-03-15 | MED | Maloney James P. | CFO | F - Tax | $36.61 | -616 | 19.5K | -3% | -$22.6K |
| M | 2024-03-19 | 2024-03-15 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | F - Tax | $36.61 | -134 | 3,917 | -3% | -$4,906 |
| M | 2024-03-19 | 2024-03-15 | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $36.61 | -3,409 | 99.8K | -3% | -$124.8K |
| 2024-03-15 | 2024-03-13 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | A - Grant | $0.00 | +2,565 | 4,051 | +173% | $0 | |
| 2024-03-15 | 2024-03-13 | MED | Chard Daniel R | COB, CEO, Dir | A - Grant | $0.00 | +45.1K | 103.2K | +78% | $0 | |
| 2024-03-15 | 2024-03-13 | MED | Maloney James P. | CFO | A - Grant | $0.00 | +8,718 | 20.1K | +76% | $0 | |
| D | 2024-03-12 | 2024-03-08 | MED | SCHLACKMAN SCOTT | Dir | M - OptEx | $27.68 | +1,300 | 11.8K | +12% | +$36.0K |
| DM | 2024-03-12 | 2024-03-08 | MED | SCHLACKMAN SCOTT | Dir | S - Sale+OE | $39.44 | -4,053 | 10.5K | -28% | -$159.9K |
| 2024-02-16 | 2024-02-14 | MED | Maloney James P. | CFO | A - Grant | $0.00 | +2,328 | 12.1K | +24% | $0 | |
| 2024-02-16 | 2024-02-14 | MED | Maloney James P. | CFO | F - Tax | $52.68 | -648 | 11.4K | -5% | -$34.1K | |
| 2024-02-16 | 2024-02-14 | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $52.68 | -5,471 | 58.1K | -9% | -$288.2K | |
| 2024-02-16 | 2024-02-14 | MED | Chard Daniel R | COB, CEO, Dir | A - Grant | $0.00 | +16.5K | 63.6K | +35% | $0 | |
| 2023-11-09 | 2023-11-07 | MED | Thomas Andrea B | Dir | P - Purchase | $68.89 | +50.39 | 6,253 | +0.8% | +$3,471 | |
| 2023-11-09 | 2023-11-07 | MED | SCHLACKMAN SCOTT | Dir | P - Purchase | $68.89 | +52.65 | 10.5K | +0.5% | +$3,627 | |
| 2023-11-09 | 2023-11-07 | MED | Hoer Michael A. | Dir | P - Purchase | $68.89 | +49.76 | 8,375 | +0.6% | +$3,428 | |
| 2023-11-09 | 2023-11-07 | MED | BROWN JEFFREY J | Dir | P - Purchase | $68.89 | +58.35 | 5,784 | +1% | +$4,020 | |
| I | 2023-11-09 | 2023-11-03 | MED | BROWN JEFFREY J | Dir | P - Purchase | $70.55 | +96.74 | 4,233 | +2% | +$6,825 |
| I | 2023-10-30 | 2023-10-06 | MED | HALLQUIST CONSTANCE J. | Former Dir | S - Sale | $73.87 | -5,613 | 2,152 | -72% | -$414.6K |
| 2023-09-15 | 2023-09-13 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | F - Tax | $81.08 | -10 | 1,486 | -0.7% | -$810.80 | |
| MI | 2023-08-16 | 2023-08-14+ | MED | BROWN JEFFREY J | Dir | S - Sale | $91.14 | -38.3K | 13.3K | -74% | -$3.49M |
| 2023-08-10 | 2023-08-08 | MED | Thomas Andrea B | Dir | P - Purchase | $89.42 | +38.12 | 6,203 | +0.6% | +$3,409 | |
| MI | 2023-08-10 | 2023-08-04 | MED | BROWN JEFFREY J | Dir | P - Purchase | $100.03 | +688.89 | 38.3K | +2% | +$68.9K |
| 2023-08-10 | 2023-08-08 | MED | BROWN JEFFREY J | Dir | P - Purchase | $89.42 | +44.14 | 5,725 | +0.8% | +$3,947 | |
| 2023-08-10 | 2023-08-08 | MED | Hoer Michael A. | Dir | P - Purchase | $89.42 | +37.64 | 8,326 | +0.5% | +$3,366 | |
| 2023-08-10 | 2023-08-08 | MED | SCHLACKMAN SCOTT | Dir | P - Purchase | $89.42 | +39.82 | 10.5K | +0.4% | +$3,561 | |
| M | 2023-07-24 | 2023-07-20 | MED | Maloney James P. | CFO | F - Tax | $94.50 | -1,142 | 9,752 | -10% | -$107.9K |
| 2023-07-24 | 2023-07-20 | MED | Maloney James P. | CFO | M - OptEx | — | +3,574 | 10.8K | +50% | — | |
| 2023-06-20 | 2023-06-15 | MED | BROWN JEFFREY J | Dir | A - Grant | $0.00 | +3,289 | 5,681 | +137% | $0 | |
| 2023-06-20 | 2023-06-15 | MED | Hoer Michael A. | Dir | A - Grant | $0.00 | +3,118 | 8,288 | +60% | $0 | |
| 2023-06-20 | 2023-06-15 | MED | SCHLACKMAN SCOTT | Dir | A - Grant | $0.00 | +3,152 | 10.4K | +43% | $0 | |
| 2023-06-20 | 2023-06-15 | MED | Thomas Andrea B | Dir | A - Grant | $0.00 | +3,118 | 6,165 | +102% | $0 | |
| 2023-06-20 | 2023-06-15 | MED | Geary Elizabeth A. | Dir | A - Grant | $0.00 | +1,781 | 1,781 | New | $0 | |
| MI | 2023-05-11 | 2023-05-05 | MED | BROWN JEFFREY J | Dir | P - Purchase | $89.74 | +753.99 | 37.7K | +2% | +$67.7K |
| 2023-05-11 | 2023-05-09 | MED | BROWN JEFFREY J | Dir | P - Purchase | $87.50 | +15.03 | 2,392 | +0.6% | +$1,315 | |
| 2023-05-11 | 2023-05-09 | MED | Thomas Andrea B | Dir | P - Purchase | $87.50 | +12.95 | 3,047 | +0.4% | +$1,133 | |
| 2023-05-11 | 2023-05-09 | MED | HALLQUIST CONSTANCE J. | Dir | P - Purchase | $87.50 | +13.34 | 7,591 | +0.2% | +$1,167 | |
| 2023-05-11 | 2023-05-09 | MED | SCHLACKMAN SCOTT | Dir | P - Purchase | $87.50 | +13.15 | 7,293 | +0.2% | +$1,151 | |
| 2023-05-11 | 2023-05-09 | MED | Hoer Michael A. | Dir | P - Purchase | $87.50 | +12.77 | 5,170 | +0.2% | +$1,117 | |
| 2023-05-01 | 2023-03-17 | MED | Maloney James P. | CFO | A - Grant | $0.00 | +4,574 | 7,320 | +167% | $0 | |
| M | 2023-05-01 | 2023-03-16+ | MED | Maloney James P. | CFO | F - Tax | $103.81 | -198 | 2,821 | -7% | -$20.6K |
| 2023-05-01 | 2023-03-16 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | F - Tax | $104.46 | -57 | 590 | -9% | -$5,954 | |
| 2023-05-01 | 2023-03-17 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | A - Grant | $0.00 | +906 | 1,496 | +154% | $0 | |
| M | 2023-05-01 | 2023-02-24+ | MED | Chard Daniel R | COB, CEO, Dir | A - Grant | $0.00 | +50.9K | 47.1K | New | $0 |
| M | 2023-05-01 | 2023-02-24+ | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $109.22 | -17.9K | 32.6K | -35% | -$1.95M |
| D | 2023-03-14 | 2023-03-10 | MED | SCHLACKMAN SCOTT | Dir | M - OptEx | $27.68 | +2,200 | 9,480 | +30% | +$60.9K |
| D | 2023-03-14 | 2023-03-10 | MED | SCHLACKMAN SCOTT | Dir | S - Sale+OE | $108.68 | -2,200 | 7,280 | -23% | -$239.1K |
| 2023-02-22 | 2023-02-21 | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $115.31 | -1,815 | 14.1K | -11% | -$209.3K | |
| 2023-02-09 | 2023-02-07 | MED | SCHLACKMAN SCOTT | Dir | P - Purchase | $114.97 | +9.80 | 7,280 | +0.1% | +$1,127 | |
| 2023-02-09 | 2023-02-07 | MED | Hoer Michael A. | Dir | P - Purchase | $114.97 | +9.53 | 5,157 | +0.2% | +$1,096 | |
| 2023-02-09 | 2022-09-13 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | F - Tax | $124.56 | -10 | 647 | -2% | -$1,246 | |
| MI | 2023-02-09 | 2023-02-03 | MED | BROWN JEFFREY J | Dir | P - Purchase | $116.11 | +571.17 | 37.0K | +2% | +$66.3K |
| 2023-02-09 | 2023-02-07 | MED | BROWN JEFFREY J | Dir | P - Purchase | $114.97 | +11.21 | 2,377 | +0.5% | +$1,289 | |
| 2023-02-09 | 2023-02-07 | MED | Thomas Andrea B | Dir | P - Purchase | $114.97 | +9.66 | 3,034 | +0.3% | +$1,111 | |
| 2023-02-09 | 2023-02-07 | MED | HALLQUIST CONSTANCE J. | Dir | P - Purchase | $114.97 | +9.95 | 7,578 | +0.1% | +$1,144 | |
| 2022-11-10 | 2022-11-08 | MED | SCHLACKMAN SCOTT | Dir | P - Purchase | $106.93 | +10.38 | 7,270 | +0.1% | +$1,110 | |
| 2022-11-10 | 2022-11-08 | MED | Hoer Michael A. | Dir | P - Purchase | $106.93 | +10.09 | 5,148 | +0.2% | +$1,079 | |
| 2022-11-10 | 2022-11-08 | MED | Thomas Andrea B | Dir | P - Purchase | $106.93 | +10.23 | 3,024 | +0.3% | +$1,094 | |
| 2022-11-10 | 2022-11-08 | MED | HALLQUIST CONSTANCE J. | Dir | P - Purchase | $106.93 | +10.54 | 7,893 | +0.1% | +$1,127 | |
| I | 2022-11-10 | 2022-11-04 | MED | BROWN JEFFREY J | Dir | P - Purchase | $105.06 | +560.97 | 36.5K | +2% | +$58.9K |
| 2022-11-10 | 2022-11-08 | MED | BROWN JEFFREY J | Dir | P - Purchase | $106.93 | +11.87 | 2,366 | +0.5% | +$1,269 | |
| MI | 2022-08-11 | 2022-08-09 | MED | BROWN JEFFREY J | Dir | P - Purchase | $126.54 | +3,940 | 410 | New | +$498.5K |
| 2022-08-10 | 2022-08-08 | MED | SCHLACKMAN SCOTT | Dir | A - Grant | $138.78 | +7.91 | 7,260 | +0.1% | +$1,098 | |
| 2022-08-10 | 2022-08-08 | MED | HALLQUIST CONSTANCE J. | Dir | A - Grant | $138.78 | +8.02 | 7,882 | +0.1% | +$1,113 | |
| 2022-08-10 | 2022-08-08 | MED | Thomas Andrea B | Dir | A - Grant | $138.78 | +7.79 | 3,014 | +0.3% | +$1,081 | |
| 2022-08-10 | 2022-08-08 | MED | Hoer Michael A. | Dir | A - Grant | $138.78 | +7.68 | 5,138 | +0.1% | +$1,066 | |
| I | 2022-08-10 | 2022-08-04 | MED | BROWN JEFFREY J | Dir | P - Purchase | $146.01 | +399.16 | 35.9K | +1% | +$58.3K |
Purchase Sale Sale after option exercise All abbreviations